Abstract:Ethnopharmacological relevanceHuanglian Jiedu Decoction (HLJDD) has the effect of clearing heat and detoxifying, and has been considered as an effective prescription for cerebral ischemia (CI) for thousands of years in traditional Chinese medicine (TCM). It can improve the quality of life of patients with ischemic stroke, but its pharmacological mechanism remains unclear.Aim of the studyThe study aimed to explore the pharmacological action and potential mechanism of HLJDD against CI by systems pharmacology, proteomics and in vivo experiments.Materials and methodsIn this study, databases such as TCMIP V2.0 and Genecards were used to predict compounds, targets and CI related targets, and network topology criteria of protein-protein interaction (PPI) network was used to screen core targets. The Database for Annotation, Visualization and Integrated Discovery database (DAVID) was used to discover biological processes and pathways. In addition, molecular docking was performed between the screened core biological active compounds and targets to verify the binding activity. Finally, proteomics and Western blot were performed on cerebral cortex tissues of middle cerebral artery occlusion (MCAO) model rats with HLJDD intervention to further verify the predicted results.Results77 compounds and 308 targets of HLJDD were identified, 54 of which were predicted to be associated with cerebral ischemia. PPI network and enrichment results showed that 8 targets, including AKT1, PTGS2 and TLR4, were core targets of HLJDD in CI. And 19 signaling pathways, including Rap1 signaling pathway, cAMP signaling pathway and arachidonic acid metabolism, were identified as key pathways to the therapeutic activity of HLJDD in CI. Combined with proteomics studies, we identified that Rap1 signaling pathway and upstream and downstream targets were the key mechanisms. Molecular biology experiments showed that RAP1A and AKT expression levels were significantly up-regulated in middle cerebral artery occlusion (MCAO) rats treated with HLJDD (P < 0.0001), GRIN1 expression level was significantly down-regulated (P < 0.0001). However, ACTB expression level was slightly down-regulated (P > 0.05), which may be related to the biological function.ConclusionThis study confirms the pharmacological effect of HLJDD on cerebral ischemia. These results indicate that HLJDD mediates various pathways such as inhibition of apoptosis, regulation of oxygen balance, inhibition of excitatory toxicity and maintenance of basic cell functions to improve CI by regulating Rap1 signaling pathway.

Progress and Significance in Research of HUI Aromatic Resuscitation Drugs in Regulation and Control of Blood-Brain Barrier

Study Progress of Mechanism of Chinese Medicine Regulating Blood-Brain Barrier Permeability of Cerebral Ischemic Injury

Research Development on the Influence of Traditional Chinese Aromatic Medicine on the Structure and Function of Blood- Brain Barrier

Advantage and thought on use of fragrant medicines in the treatment of ischemic brain injury

Overview in Empirical Study of Effect of Drugs for Inducing Resuscitation on Blood-brain Barrier

Experimental studies on protective effects of Yangyin Yiqi Huoxue infusion (养阴益气活血冲剂) on cerebral ischemiareperfusion injury

Research progress on the pharmacological mechanisms of chinese medicines that tonify Qi and activate blood against cerebral ischemia/reperfusion injury

Progress in drugs for cerebral ischemia therapy

Research progress of natural products for the treatment of ischemic stroke

Application and mechanisms of Sanhua Decoction in the treatment of cerebral ischemia-reperfusion injury

Research Development on the Protection of the Active Constituent of Ligusticum Chuanxiong Hort Against Ischemic Cerebrovascular Disease

Huangqi-Honghua combination and its main components ameliorate cerebral infarction with Qi deficiency and blood stasis syndrome by antioxidant action in rats

Systems pharmacology, proteomics and in vivo studies identification of mechanisms of cerebral ischemia injury amelioration by Huanglian Jiedu Decoction

Borneol for Regulating the Permeability of the Blood-Brain Barrier in Experimental Ischemic Stroke: Preclinical Evidence and Possible Mechanism

Research Progress on Neuroprotective Effects of Isoquinoline Alkaloids

Natural herbal extract roles and mechanisms in treating cerebral ischemia: A systematic review

The Protective Effect of Liquiritin in Hypoxia/Reoxygenation-Induced Disruption on Blood Brain Barrier

Progress on the Protective Effect of Compounds from Natural Medicines on Cerebral Ischemia.

Research Progress in Understanding the Relationship Between Heme Oxygenase-1 and Intracerebral Hemorrhage

Research progress on the mechanism of action of hesperetin in cerebral ischemia: a narrative review

Exploring the Regulatory Mechanism of Hedysarum Multijugum Maxim.-Chuanxiong Rhizoma Compound on HIF-VEGF Pathway and Cerebral Ischemia-Reperfusion Injury’s Biological Network Based on Systematic Pharmacology